Laronidase · ALDURAZYME

Protein / enzyme therapeutic

Approvedregulatory verdict

Evidence outlook

Approved: Mucopolysaccharidosis Type I

Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.

track record: Weak signal

Also approved (2)
JP
  • MPS I
Product first approved 2006biospace.com
EU
  • Long-term enzyme replacement therapy in confirmed MPS I
Product first approved 2003EMA

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.

Phase 3 (4)
Other / comorbidity
NCT06406153 · Cinnagen
2022-09-10 – 2023-11-18 · Mucopolysaccharidosis Type 1
What this study did
NCT00146770 · Genzyme, a Sanofi Company
2001-05 – 2005-03 · Mucopolysaccharidosis I, Hurler's Syndrome, Hurler-Scheie Syndrome, Scheie Syndrome
What this study did
NCT00912925 · Genzyme, a Sanofi Company
2000-12 – 2001-09 · Mucopolysaccharidosis I, Hurlers Syndrome, Hurler-Scheie Syndrome
What this study did
Phase 2 (2)
Other / comorbidity
NCT00176891 · Masonic Cancer Center, University of Minnesota
2004-03 – 2012-11 · Mucopolysaccharidosis I, Hurler Syndrome
What this study did
NCT00146757 · Genzyme, a Sanofi Company
2002-10 – 2005-05 · Mucopolysaccharidosis I, Hurler Syndrome, Hurler-Scheie Syndrome, Scheie Syndrome
What this study did
Phase 1/2 (1)
Other / comorbidity
Phase 1 (5)
Other / comorbidity
NCT04532047 · University of California, San Francisco
2021-07-01 – 2032-07-31 · MPS I, MPS II, MPS IVA, MPS VI, Mps VII, Gaucher Disease, Type 2, Gaucher Disease, Type 3, Pompe Disease Infantile-Onset, Wolman Disease
What this study did
NCT00638547 · Masonic Cancer Center, University of Minnesota
2008-01-02 – 2018-11-18 · Hurler Syndrome
What this study did
NCT01173016 · Masonic Cancer Center, University of Minnesota
2012-05-29 – 2016-03-04 · Hurler Syndrome
What this study did
NCT00786968 · Patricia I. Dickson, M.D.
2008-01 – 2011-10 · Spinal Cord Compression, Mucopolysaccharidosis I, Hurler-Scheie Syndrome, Scheie Syndrome, Lysosomal Storage Disease
What this study did
NCT00215527 · Patricia I. Dickson, M.D.
2005-11 – 2011-10 · Mucopolysaccharidosis I, Lysosomal Storage Diseases, Spinal Cord Compression
What this study did
Phase 4 (4)
Other / comorbidity
NCT05134571 · Genzyme, a Sanofi Company
2021-10-28 – 2023-07-26 · Mucopolysaccharidosis I
What this study did
NCT00418821 · Genzyme, a Sanofi Company
2010-10-22 – 2022-12-21 · Mucopolysaccharidosis I, Hurler's Syndrome, Hurler-Scheie Syndrome, Scheie
What this study did
NCT00144768 · Genzyme, a Sanofi Company
2004-07 – 2007-05 · Mucopolysaccharidosis I, Hurler's Syndrome, Hurler-Scheie Syndrome, Scheie's Syndrome
What this study did
NCT00144781 · Genzyme, a Sanofi Company
2004-12 – 2006-01 · Mucopolysaccharidosis I, Hurler's Syndrome, Hurler-Scheie Syndrome, Scheie Syndrome
What this study did
Early phase / not applicable (1)
Other / comorbidity
NCT00852358 · Patricia I. Dickson, M.D.
2009-06 – 2015-04 · Cognitive Decline, Mucopolysaccharidosis I, Hurler-Scheie Syndrome, Scheie Syndrome, Lysosomal Storage Disease
What this study did

Competitive landscape

No competitors sharing a mechanism or indication in the current universe.

Upcoming events

(1 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow ALDURAZYME (Laronidase) to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2031 (1)
July 2031 (1)
Phase 1MPS I, MPS II, MPS IVA, MPS VI, Mps VII, Gaucher Disease, Type 2, Gaucher Disease, Type 3, Pompe Disease Infantile-Onset, Wolman DiseaseRecruiting
Est. primary completion 2031-07-31 · NCT04532047 · CT.gov ↗
What to watch

See the full readout calendar ↗